ELDERLY PATIENTS ARE NOT AT INCREASED RISK OF SERIOUS INFECTIONS WHEN RECEIVING BDMARDS OR JAK INHIBITORS COMPARED TO CSDMARD TREATMENT

Strangfeld A, Manger B, Worsch M, Schmeiser T, Zink A, Schaefer M (2021)

Publication Type: Conference contribution

Publication year: 2021

Journal

Annals of the Rheumatic Diseases BMJ Publishing Group

Publisher: BMJ PUBLISHING GROUP

City/Town: LONDON

Pages Range: 64-65

Conference Proceedings Title: ANNALS OF THE RHEUMATIC DISEASES

DOI: 10.1136/annrheumdis-2021-eular.763

Authors with CRIS profile

Bernhard Manger Professur für Rheumatologie und Klinische Immunologie

Involved external institutions

Deutsches Rheuma-Forschungszentrum (DRFZ) DE Germany (DE)

How to cite

APA:

Strangfeld, A., Manger, B., Worsch, M., Schmeiser, T., Zink, A., & Schaefer, M. (2021). ELDERLY PATIENTS ARE NOT AT INCREASED RISK OF SERIOUS INFECTIONS WHEN RECEIVING BDMARDS OR JAK INHIBITORS COMPARED TO CSDMARD TREATMENT. In ANNALS OF THE RHEUMATIC DISEASES (pp. 64-65). LONDON: BMJ PUBLISHING GROUP.

MLA:

Strangfeld, A., et al. "ELDERLY PATIENTS ARE NOT AT INCREASED RISK OF SERIOUS INFECTIONS WHEN RECEIVING BDMARDS OR JAK INHIBITORS COMPARED TO CSDMARD TREATMENT." Proceedings of the ANNALS OF THE RHEUMATIC DISEASES LONDON: BMJ PUBLISHING GROUP, 2021. 64-65.

BibTeX: Download